Praxis Precision Medicines Income Statement (2019-2026) | PRAX

Income Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
0.68M0.78M0.47M0.52M0.43M0.36M0.30M7.46M
Operating items
Research & Development (Quarter)
25.68M33.14M43.51M52.65M43.62M30.44M28.33M25.50M25.61M17.26M18.39M26.98M27.26M41.88M56.29M60.81M63.01M65.80M77.51M77.99M
Selling, General & Administrative (Quarter)
10.80M11.63M15.15M16.20M16.77M13.85M13.12M13.27M10.13M8.72M9.93M15.33M10.59M15.26M15.13M13.92M13.06M12.56M19.54M27.87M
Operating Expenses (Quarter)
36.48M44.77M58.66M68.85M60.39M44.29M41.45M38.77M35.74M25.98M28.32M42.32M37.84M57.14M71.42M74.73M76.07M78.36M97.04M105.86M
Operating Income (Quarter)
-36.48M-44.77M-58.66M-68.85M-60.39M-44.29M-41.45M-38.09M-34.96M-25.52M-27.81M-41.89M-37.49M-56.84M-63.96M-74.73M-76.07M-78.36M-97.04M-105.86M
EBIT (Quarter)
-36.48M-44.77M-58.66M-68.85M-60.39M-44.29M-41.45M-38.09M-34.96M-25.52M-27.81M-41.89M-37.49M-56.84M-63.96M-74.73M-76.07M-78.36M-97.04M-105.86M
Non-operating items
Interest & Investment Income (Quarter)
0.04M-0.43M-0.07M0.14M1.32M0.15M0.02M0.00M-0.07M1.40M0.01M-0.26M-2.16M
Other Non Operating Income (Quarter)
0.08M0.07M0.13M0.20M0.34M0.28M0.64M0.65M0.88M0.93M2.33M4.81M4.92M5.28M5.43M4.94M4.42M8.13M13.30M
Non Operating Income (Quarter)
0.08M0.07M0.07M0.13M0.20M0.34M0.28M0.64M0.65M0.88M0.93M2.33M4.81M4.92M5.28M5.43M4.94M4.42M8.13M13.30M
Net income details
EBT (Quarter)
-36.40M-44.70M-58.59M-83.31M-61.22M-43.95M-184.07M-37.96M-35.01M-25.74M-208.31M-56.08M-39.27M-68.23M-282.26M-75.84M-77.90M-87.02M-403.64M-562.09M
Tax Provisions (Quarter)
0.01M-0.01M
Profit After Tax (Quarter)
-36.40M-44.70M-58.58M-68.72M-60.19M-43.95M-41.17M-37.45M-34.31M-24.63M-26.88M-39.55M-32.68M-51.91M-58.68M-69.30M-71.13M-73.93M-88.94M-92.60M
Income from Continuing Operations (Quarter)
-36.40M-44.70M-58.58M-83.31M-61.22M-43.95M-184.07M-37.96M-35.01M-25.74M-208.31M-56.08M-39.27M-68.23M-282.26M-75.84M-77.90M-87.02M-403.64M-562.09M
Consolidated Net Income (Quarter)
-36.40M-44.70M-58.58M-83.31M-61.22M-43.95M-184.07M-37.96M-35.01M-25.74M-208.31M-56.08M-39.27M-68.23M-282.26M-75.84M-77.90M-87.02M-403.64M-562.09M
Income towards Parent Company (Quarter)
-36.40M-44.70M-58.58M-83.31M-61.22M-43.95M-184.07M-37.96M-35.01M-25.74M-208.31M-56.08M-39.27M-68.23M-282.26M-75.84M-77.90M-87.02M-403.64M-562.09M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)
-36.40M-44.70M-58.58M-83.31M-61.22M-43.95M-184.07M-37.96M-35.01M-25.74M-208.31M-56.08M-39.27M-68.23M-282.26M-75.84M-77.90M-87.02M-403.64M-562.09M
Additional items
EPS (Basic) (Quarter)
-13.13-15.00-20.70-27.49-20.16-14.40-59.89-10.72-7.53-2.85-31.59-4.03-2.09-3.61-15.76-3.60-3.63-3.96-17.94-19.46
EPS (Diluted) (Quarter)
-13.13-15.00-20.70-27.49-20.16-14.40-59.89-10.72-7.53-2.85-31.59-4.03-2.09-3.61-15.76-3.60-3.63-3.96-17.94-19.46
Shares Outstanding (Quarter)
2.77M2.98M2.83M3.03M3.04M3.05M3.07M3.54M4.65M9.04M6.59M13.90M18.82M18.88M17.91M21.06M21.47M21.98M22.50M28.88M
Shares Outstanding (Diluted) (Quarter)
2.77M2.98M2.83M3.03M3.04M3.05M3.07M3.54M4.65M9.04M6.59M13.90M18.82M18.88M17.91M21.06M21.47M21.98M22.50M28.88M
Shares Outstanding (Entity) (Quarter)
2.98M2.99M3.02M3.03M3.04M3.12M3.29M3.86M4.65M8.57M6.59M13.26M17.76M17.79M19.42M20.34M21.04M21.17M25.20M27.86M
EBITDA (Quarter)
-36.48M-44.77M-58.66M-68.85M-60.39M-44.29M-41.45M-38.09M-34.96M-25.52M-27.81M-41.89M-37.49M-56.84M-63.96M-74.73M-76.07M-78.36M-97.04M-105.86M
Interest Expenses (Quarter)
56.59M54.15M86.00M14.03M0.75M0.54M143.93M0.02M0.07M0.22M180.50M14.20M1.71M12.80M218.30M1.12M1.57M8.66M306.60M454.07M
Tax Rate (Quarter)
-0.01%0.01%